Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Drugs in Development
Details:
Lutropin Alfa is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infertility, Female.
Lead Product(s): Lutropin Alfa,Follitropin Alfa
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Protein
Sponsor: Merck Group
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 06, 2022
Lead Product(s) : Lutropin Alfa,Follitropin Alfa
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Merck Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders
Details : Lutropin Alfa is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infertility, Female.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
June 06, 2022
Details:
Follitropin Alfa is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infertility.
Lead Product(s): Follitropin Alfa,Lutropin Alfa
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Hormone
Sponsor: Merck Group
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 22, 2021
Lead Product(s) : Follitropin Alfa,Lutropin Alfa
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Merck Group
Deal Size : Inapplicable
Deal Type : Inapplicable
PErsonalized Addition of Recombinant LH in Ovarian Stimulation
Details : Follitropin Alfa is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infertility.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
January 22, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info :
Registration Country : Norway
Follitropin alfa, Lutropin alfa
Brand Name : Pergoveris
Dosage Form : Solution for injection in a pre-filled pen
Dosage Strength : 300IE/150IE
Packaging : Pre-filled pen 0.48ml, pcs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Follitropin Alfa; Lutropin Alfa
Brand Name : Pergoveris
Dosage Form : Solution For Injection
Dosage Strength : 300IU/0.48ml;150IU/0.48ml
Packaging :
Approval Date : 08/05/2017
Application Number : 20160628000289
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Lutropin Alfa; Folitropin Alfa
Brand Name : Pergoveris
Dosage Form : Powder And Solvent For Injectable Solution
Dosage Strength : 150IU; 75 IU
Packaging :
Approval Date : 2013-07-01
Application Number : 107396002
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Lutropin Alfa; Folitropin Alfa
Brand Name : Pergoveris (
Dosage Form : Injectable Solution
Dosage Strength : 450IU; 225IU
Packaging :
Approval Date : 2017-10-04
Application Number : 107396005
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Lutropin Alfa; Folitropin Alfa
Brand Name : Pergoveris (
Dosage Form : Injectable Solution
Dosage Strength : 300IU; 150IU
Packaging :
Approval Date : 2017-10-02
Application Number : 107396004
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Lutropin Alfa; Folitropin Alfa
Brand Name : Pergoveris
Dosage Form : Powder And Solvent For Injectable Solution
Dosage Strength : 150IU; 75 IU
Packaging :
Approval Date : 2007-07-03
Application Number : 07396003
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Allowed
Registration Country : Switzerland
Follitropin Alfa; Lutropin Alfa
Brand Name : Pergoveris
Dosage Form : Solution For Injection
Dosage Strength :
Packaging :
Approval Date : 13/05/2008
Application Number : 58154
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Follitropin Alfa; Lutropin Alfa
Brand Name : Pergoveris Pen IE IE
Dosage Form : Injectable Solution
Dosage Strength :
Packaging :
Approval Date : 13/04/2018
Application Number : 66608
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Follitropin Alfa; Lutropin Alfa
Brand Name : Pergoveris
Dosage Form : Powder For Solution For Injection
Dosage Strength :
Packaging :
Approval Date : 28/03/2024
Application Number : 69476
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Luveris
Dosage Form : Solution For Injection
Dosage Strength : 3.7mcg/ml
Packaging :
Approval Date : 27/09/2002
Application Number : 55430
Regulatory Info : Allowed
Registration Country : Switzerland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
